Rockefeller Capital Management L.P. Atara Biotherapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$2.85 - $8.73 $29,982 - $91,839	10,520 Added 24.23%	53,936 $203,000
Q2 2022 Aug 12, 2022	BUY	$4.69 - $9.84 $23,450 - $49,200	5,000 Added 13.02%	43,416 $338,000
Q1 2022 May 13, 2022	SELL	$8.44 - $16.89 $4,220 - $8,445	-500 Reduced 1.28%	38,416 $356,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $19.89 $13,465 - $18,219	916 Added 2.41%	38,916 $613,000
Q3 2021 Nov 12, 2021	BUY	$11.99 - $17.9 $176,852 - $264,025	14,750 Added 63.44%	38,000 $680,000
Q2 2021 Aug 10, 2021	SELL	$12.89 - $16.58 $96,675 - $124,349	-7,500 Reduced 24.39%	23,250 $361,000
Q1 2021 May 11, 2021	BUY	$14.0 - $20.72 $115,500 - $170,940	8,250 Added 36.67%	30,750 $441,000
Q3 2020 Nov 13, 2020	BUY	$11.92 - $15.87 $268,200 - $357,075	22,500 New	22,500 $291,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.